000 | 02011 a2200565 4500 | ||
---|---|---|---|
005 | 20250517132242.0 | ||
264 | 0 | _c20171128 | |
008 | 201711s 0 0 eng d | ||
022 | _a1536-3694 | ||
024 | 7 |
_a10.1097/FTD.0000000000000361 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBilling, Heiko | |
245 | 0 | 0 |
_aSingle-Nucleotide Polymorphism of CYP3A5 Impacts the Exposure to Tacrolimus in Pediatric Renal Transplant Recipients: A Pharmacogenetic Substudy of the TWIST Trial. _h[electronic resource] |
260 |
_bTherapeutic drug monitoring _c02 2017 |
||
300 |
_a21-28 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAlleles |
650 | 0 | 4 | _aArea Under Curve |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 |
_aCytochrome P-450 CYP3A _xgenetics |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Frequency |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
650 | 0 | 4 |
_aKidney Transplantation _xmethods |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMultidrug Resistance-Associated Protein 2 |
650 | 0 | 4 |
_aMycophenolic Acid _xadministration & dosage |
650 | 0 | 4 | _aPharmacogenetics |
650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
650 | 0 | 4 |
_aTacrolimus _xadministration & dosage |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aHöcker, Britta | |
700 | 1 | _aFichtner, Alexander | |
700 | 1 | _avan Damme-Lombaerts, Rita | |
700 | 1 | _aFriman, Styrbjorn | |
700 | 1 | _aJaray, Jenö | |
700 | 1 | _aVondrak, Karel | |
700 | 1 | _aSarvary, Eniko | |
700 | 1 | _aDello Strologo, Luca | |
700 | 1 | _aOellerich, Michael | |
700 | 1 | _avon Ahsen, Nicolas | |
700 | 1 | _aTönshoff, Burkhard | |
773 | 0 |
_tTherapeutic drug monitoring _gvol. 39 _gno. 1 _gp. 21-28 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/FTD.0000000000000361 _zAvailable from publisher's website |
999 |
_c26737507 _d26737507 |